Post-Marketing Surveillance of Acarbose Treatment in Patients with Type 2 Diabetes Mellitus and Subjects with Impaired Glucose Tolerance in China

Author： Pan Chang-Yu

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.27, Iss.6, 2007-01, pp. : 397-405

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Postmarketing Surveillance of Acarbose Treatment in Taiwanese Patients with Type 2 Diabetes Mellitus

By Hung Yi-Jen

Clinical Drug Investigation, Vol. 26, Iss. 10, 2006-01 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

Evaluation of the Efficacy and Tolerability of Acarbose in Patients with Diabetes Mellitus: A Postmarketing Surveillance Study

By Spengler M. Schmitz H. Landen H.

Clinical Drug Investigation, Vol. 25, Iss. 10, 2005-01 ,pp. : 651-659

Adis International

Access to resources Recommend Favorite

Effect of Cilostazol on Lipid, Uric Acid and Glucose Metabolism in Patients with Impaired Glucose Tolerance or Type 2 Diabetes Mellitus: A Double-Blind, Placebo-Controlled Study

By Toyota T.

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 325-335

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance Study of the Efficacy and Tolerability of Pioglitazone in Insulin-Resistant Patients with Type 2 Diabetes Mellitus in General Practice

By Schöfl C.

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite

Safety and Tolerability of Acarbose in the Treatment of Type 1 and Type 2 Diabetes Mellitus

By Neuser Dieter

Clinical Drug Investigation, Vol. 25, Iss. 9, 2005-01 ,pp. : 579-587

Adis International

Access to resources Recommend Favorite